Namocatcat, Allan B.
HRN: 28-01-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/29/2025
11/04/2025
IV
4.5
Q8h
Sepsis Sec To Capmr
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes